RT Banner 2021V4.gif

China Daily

News> Nation> Content
Monday, December 21, 2020, 21:25
China starts building COVID-19 vaccine production facility
By Xinhua
Monday, December 21, 2020, 21:25 By Xinhua

A staff member displays samples of the COVID-19 inactivated vaccine at Sinovac Biotech Ltd, in Beijing, March 16, 2020. (PHOTO / XINHUA)

KUNMING - China started the construction on Monday of a plant for manufacturing an mRNA-based COVID-19 vaccine, with production operations due to begin in eight months, according to local authorities.

The facility in the city of Yuxi, in southwest China's Yunnan Province, is expected to produce 120 million doses per year in its first phase, with key manufacturing equipment and core ingredients all independently developed by China.

The facility in the city of Yuxi, in southwest China's Yunnan Province, is expected to produce 120 million doses per year in its first phase, with key manufacturing equipment and core ingredients all independently developed by China

ALSO READ: Chinese vaccines show effective protection against COVID-19

The vaccine was approved by the National Medical Products Administration for clinical drug trials on June 19, 2020, and is about to enter phase-II clinical trials.

It was jointly developed by the Academy of Military Medical Sciences, Suzhou Abogen Biosciences and Yunnan-based Walvax Biotechnology Co., Ltd.

In phase-I clinical trials, the vaccine was shown to be safe with good immunogenicity, and it has excellent stability in storage at 2-8 degrees Celsius, according to the vaccine developers.

READ MORE: China's COVID-19 vaccine capacity to reach 610 million

The mRNA in the vaccine enters human cells and expresses antigens, which induces the immune system to respond so that the body can obtain immunity.


Share this story

CHINA DAILY
HONG KONG NEWS
OPEN
Please click in the upper right corner to open it in your browser !